Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Multiple modality approach to assess adherence to medications across time in Multiple Sclerosis.

Neter E, Wolkowitz A, Glass-Marmor L, Lavi I, Ratzabi S, Leibkovitz I, Miller A.

Mult Scler Relat Disord. 2020 Jan 15;40:101951. doi: 10.1016/j.msard.2020.101951. [Epub ahead of print]

PMID:
32004857
2.

Caring for patients with venomous Crotalinae snakebites.

Miller A, Parsh B.

Nursing. 2020 Feb;50(2):56-60. doi: 10.1097/01.NURSE.0000651632.09894.b4. Review.

PMID:
31977807
3.

Fingolimod reduces CXCR4-mediated B cell migration and induces regulatory B cells-mediated anti-inflammatory immune repertoire.

Blumenfeld-Kan S, Staun-Ram E, Miller A.

Mult Scler Relat Disord. 2019 Sep;34:29-37. doi: 10.1016/j.msard.2019.06.016. Epub 2019 Jun 18.

PMID:
31228713
4.

Dimethyl fumarate as a first- vs second-line therapy in MS: Focus on B cells.

Staun-Ram E, Najjar E, Volkowich A, Miller A.

Neurol Neuroimmunol Neuroinflamm. 2018 Oct 16;5(6):e508. doi: 10.1212/NXI.0000000000000508. eCollection 2018 Nov.

5.

Exhaled Breath Markers for Nonimaging and Noninvasive Measures for Detection of Multiple Sclerosis.

Broza YY, Har-Shai L, Jeries R, Cancilla JC, Glass-Marmor L, Lejbkowicz I, Torrecilla JS, Yao X, Feng X, Narita A, Müllen K, Miller A, Haick H.

ACS Chem Neurosci. 2017 Nov 15;8(11):2402-2413. doi: 10.1021/acschemneuro.7b00181. Epub 2017 Aug 16.

PMID:
28768105
6.

Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins.

Mamrut S, Avidan N, Truffault F, Staun-Ram E, Sharshar T, Eymard B, Frenkian M, Pitha J, de Baets M, Servais L, Berrih-Aknin S, Miller A.

J Autoimmun. 2017 Aug;82:62-73. doi: 10.1016/j.jaut.2017.05.005. Epub 2017 May 24.

PMID:
28549776
7.

Effector and regulatory B cells in Multiple Sclerosis.

Staun-Ram E, Miller A.

Clin Immunol. 2017 Nov;184:11-25. doi: 10.1016/j.clim.2017.04.014. Epub 2017 Apr 28. Review.

PMID:
28461106
8.

Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules.

Nakhleh MK, Amal H, Jeries R, Broza YY, Aboud M, Gharra A, Ivgi H, Khatib S, Badarneh S, Har-Shai L, Glass-Marmor L, Lejbkowicz I, Miller A, Badarny S, Winer R, Finberg J, Cohen-Kaminsky S, Perros F, Montani D, Girerd B, Garcia G, Simonneau G, Nakhoul F, Baram S, Salim R, Hakim M, Gruber M, Ronen O, Marshak T, Doweck I, Nativ O, Bahouth Z, Shi DY, Zhang W, Hua QL, Pan YY, Tao L, Liu H, Karban A, Koifman E, Rainis T, Skapars R, Sivins A, Ancans G, Liepniece-Karele I, Kikuste I, Lasina I, Tolmanis I, Johnson D, Millstone SZ, Fulton J, Wells JW, Wilf LH, Humbert M, Leja M, Peled N, Haick H.

ACS Nano. 2017 Jan 24;11(1):112-125. doi: 10.1021/acsnano.6b04930. Epub 2016 Dec 21.

9.

Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.

Golan D, Miller A, Sotirchos ES, Bhargava P, Calabresi PA.

Neurology. 2016 Jul 26;87(4):446. doi: 10.1212/01.wnl.0000490142.79912.ff. No abstract available.

PMID:
27462040
10.

Shifting paradigms in multiple sclerosis: from disease-specific, through population-specific toward patient-specific.

Golan D, Staun-Ram E, Miller A.

Curr Opin Neurol. 2016 Jun;29(3):354-61. doi: 10.1097/WCO.0000000000000324. Review.

PMID:
27070218
11.

Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.

Blumenfeld S, Staun-Ram E, Miller A.

J Autoimmun. 2016 Jun;70:40-51. doi: 10.1016/j.jaut.2016.03.012. Epub 2016 Apr 4.

PMID:
27055778
12.

Effect of Fampridine-PR (prolonged released 4-aminopyridine) on the manual functions of patients with Multiple Sclerosis.

Savin Z, Lejbkowicz I, Glass-Marmor L, Lavi I, Rosenblum S, Miller A.

J Neurol Sci. 2016 Jan 15;360:102-9. doi: 10.1016/j.jns.2015.11.035. Epub 2015 Dec 2.

PMID:
26723984
13.

Cognitive Function of Patients with Crohn's Disease is Associated with Intestinal Disease Activity.

Golan D, Gross B, Miller A, Klil-Drori S, Lavi I, Shiller M, Honigman S, Almog R, Segol O.

Inflamm Bowel Dis. 2016 Feb;22(2):364-71. doi: 10.1097/MIB.0000000000000594.

PMID:
26398711
14.

Integrative analysis of methylome and transcriptome in human blood identifies extensive sex- and immune cell-specific differentially methylated regions.

Mamrut S, Avidan N, Staun-Ram E, Ginzburg E, Truffault F, Berrih-Aknin S, Miller A.

Epigenetics. 2015;10(10):943-57. doi: 10.1080/15592294.2015.1084462.

15.

VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis.

Avidan N, Le Panse R, Harbo HF, Bernasconi P, Poulas K, Ginzburg E, Cavalcante P, Colleoni L, Baggi F, Antozzi C, Truffault F, Horn-Saban S, Pöschel S, Zagoriti Z, Maniaol A, Lie BA, Bernard I, Saoudi A, Illes Z, Casasnovas Pons C, Melms A, Tzartos S, Willcox N, Kostera-Pruszczyk A, Tallaksen C, Mantegazza R, Berrih-Aknin S, Miller A.

Ann Clin Transl Neurol. 2014 May;1(5):329-39. doi: 10.1002/acn3.51. Epub 2014 Apr 11.

16.

Gene expression profiling of the response to interferon beta in Epstein-Barr-transformed and primary B cells of patients with multiple sclerosis.

Khsheibun R, Paperna T, Volkowich A, Lejbkowicz I, Avidan N, Miller A.

PLoS One. 2014 Jul 15;9(7):e102331. doi: 10.1371/journal.pone.0102331. eCollection 2014.

17.

Revised diagnostic criteria of multiple sclerosis.

Milo R, Miller A.

Autoimmun Rev. 2014 Apr-May;13(4-5):518-24. doi: 10.1016/j.autrev.2014.01.012. Epub 2014 Jan 12. Review.

PMID:
24424194
18.

Genetic basis of myasthenia gravis - a comprehensive review.

Avidan N, Le Panse R, Berrih-Aknin S, Miller A.

J Autoimmun. 2014 Aug;52:146-53. doi: 10.1016/j.jaut.2013.12.001. Epub 2013 Dec 19. Review.

PMID:
24361103
19.

T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: role of IL-2.

Ben-Ami E, Miller A, Berrih-Aknin S.

Autoimmun Rev. 2014 Feb;13(2):187-96. doi: 10.1016/j.autrev.2013.09.007. Epub 2013 Oct 11.

PMID:
24121085
20.

Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties.

Golan D, Halhal B, Glass-Marmor L, Staun-Ram E, Rozenberg O, Lavi I, Dishon S, Barak M, Ish-Shalom S, Miller A.

BMC Neurol. 2013 Jun 14;13:60. doi: 10.1186/1471-2377-13-60.

Supplemental Content

Loading ...
Support Center